Copyright
©The Author(s) 2023.
World J Diabetes. Feb 15, 2023; 14(2): 110-119
Published online Feb 15, 2023. doi: 10.4239/wjd.v14.i2.110
Published online Feb 15, 2023. doi: 10.4239/wjd.v14.i2.110
Figure 3 Haematoxylin and eosin staining of the hearts of rats in each group (400×).
A: Normal control group; B: Model group; C: Low-dose liraglutide group; D: High-dose liraglutide group.
- Citation: Xue DD, Zhang X, Li DW, Yang YL, Liu JJ. Protective effect of liraglutide on the myocardium of type 2 diabetic rats by inhibiting polyadenosine diphosphate-ribose polymerase-1. World J Diabetes 2023; 14(2): 110-119
- URL: https://www.wjgnet.com/1948-9358/full/v14/i2/110.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i2.110